EDUCATION
+) Degree in Medicine and Surgery from the Faculty of Medicine and Surgery, University of
Parma
+) Specialization in Psychiatry from the Institute of Clinical Psychiatry, Faculty of Medicine
and Surgery, University of Parma
+) Master's Degree in Developmental Psychology from the Faculty of Psychology, University of
Parma
+) PhD in "Experimental Clinical Neuroscience and Psychiatry Curriculum: Early Intervention in Psychotic Onset and Mood Disorders" from the Faculty of Medicine and Surgery (Department of Neuroscience), University of Rome "La Sapienza"
+) October 2022-October 2025: Fixed-term Researcher in Psychiatry from the Department of Neuroscience Biomedical and Neuromotor Sciences at the University of Bologna.
+) October 2025 to present - Associate Professor in Psychiatry at the Department of Biomedical and Neuromotor Sciences of the University of Bologna.
Occupations
+) Fixed-term Psychiatry Medical Doctor at the "Istituti Ospitalieri" Hospital of
Cremona, working at the SPDC of the "Oglio Po" Hospital in Casalmaggiore (CR);
+) Permanent Psychiatry Medical Docgtor at the AUSL IRCCS of Reggio Emilia (RE),
working at the CSM of Guastalla (RE) and the CSM "Via Petrella" of Reggio Emilia, where I was
director of the service;
+) Permanent Psychiatry Medical Doctor at the AUSL of Parma (PR), working at the
RTI "Santi" of Parma, the RTE "I Maggio" of Colorno, the REMS of Parma, and in penitentiary institutions of Parma (where I was director of the service).
+) Since 2016, member of the regional technical group "Psychotic Onsets" of the Emilia-Romagna Region.
+) October 2022-October 2025: fixed-term "Senior" Researcher in Psychiatry (Assistant Professor) at the Department of Biomedical and Neuromotor Sciences (DIBINEM) of the Alma Mater Studiorum University of Bologna, with a clinical practice agreement with the Bologna Local Health Authority, working at the "Saragozza" Mental Health Center in Bologna and the "Arcipelago" psychiatric facility of Bologna.
+) October 2025 to date: Associate Professor in Psychiatry at the Department of Biomedical and Neuromotor Sciences of the University of Bologna, with an agreement for clinical activity (Consultant Psychiatrist) at the AUSL of Bologna, service carried out at the Adult Mental Health Service ("Saragozza") of Bologna and RTI "Arcipelago" psychiatric facility.
PUBLICATIONS (The last 2 years)
Alfieri M,…,Pelizza L, Menchetti M. “Dissociation and dysfunctional personality traits in patients with borderline personality disorder: a study based on DSM-5 alternative model”. The European Journal of Psychiatry 2025; 39: 100283. https://doi.org/10.1016/j.ejpsy.2024.100283.
Pelizza L, et al. “Baseline exposure to antipsychotic medication in young people at clinical high risk for psychosis: a 2-year Italian follow-up study”. Human Psychopharmacology: clinical and experimental 2025; 40: e70003. https://doi.org/10.1002/hup.70003.
Pelizza L, et al. “Sex comparisons on the beneficial effects of an early intervention program in a patients’ cohort with first episode psychosis: what effectiveness in women?” Archives of Women’s Mental Health 2025; https://doi.org/10.1007/s00737-025-01566-1.
Pelizza L, et al. “Psychiatric antecedents in young patients with first episode psychosis: what relevance for clinical outcomes?”. European Archives of Psychiatry and Clinical Neuroscience 2025; February 28th. https://doi.org/10.1007/s00406-025-01981-6.
Pellegrini P,…,Pelizza L. “Suggestions on early psychosis: towards a new psychopathology?”. Academia Mental Health & Well-Being 2025; 2: 1-8. https://doi.org/10.20935/MHealthWellB7584.
Pelizza L, et al. “What autism in first episode psychosis? Results from a 2-year follow-up study”. European Archives of Psychiatry and Clinical Neuroscience 2025; March 5th. https://doi.org/10.1007/s00406-025-01986-1.
Pelizza L, et al. “Compulsory treatment across 2-year follow-up within an “Early Intervention in Psychosis” program in Italy: incidence rate and baseline predictors”. Schizophrenia Research 2025; 279: 1-12. https://doi.org/10.1016/j.schres.2025.03.028.
Pelizza L, et al. “Compulsory admission as access to early intervention service for patients with first episode psychosis: what relevance for clinical outcomes? Further findings from the Pr-EP program”. Psychiatry Research 2025; 349: 116507. https://doi.org/10.1016/j.psychres.2025.116507.
Pelizza L, et al. “Autism characteristics in young patients with first episode of schizophrenia spectrum disorder: findings from a 2-year longitudinal research”. Journal of Psychiatric Research 2025; 186: 407-425. https://doi.org/10.1016/j.jpsychires.2025.04.041.
Merola GP, Patti A, Catania G, Baccaredda Boy O, …, Pelizza L, …, Ricca V. “Phenomenological psychopathology meets machine learning: a multicentric retrospective study (Mu.St.A.R.D.) targeting the role of aberrant salience assessment in psychosis detection”. Schizophrenia Research 2025; 281: 147-156. https://doi.org/10.1016/j.schres.2025.04.028.
Martinelli A, Leone S, …, Pelizza L, et al. “Sex differences in schizophrenia spectrum disorders: insights from the DiAPAson study using a data-driven approach”. Social Psychiatry and Psychiatric Epidemiology 2025; https://doi.org/10.1007/s00127-025-02855-x.
Baldini V, Pasquino F, ..., Pelizza L, Menchetti M. “Sleep disturbances in individuials with first episode psychosis and clinical high-risk states: a systematic review”. Schizophrenia Research 2025; 282: 123-132. https://doi.org/10.1016/j.schres.2025.06.008.
Pelizza L, et al. “Suicidality in youths at clinical high risk for psychosis: a neglected public health concern”. European Child and Adolescent Psychiatry 2025; https://doi.org/10.1007/s00787-025-02798-3.
Pelizza L, et al. “Autism-spectrum traits in First Episode Psychosis: psychopathological and prognostic considerations from a 2-year follow-up study”. Schizophrenia Research 2025; 283: 163-172. https://doi.org/10.1016/j.schres.2025.07.014.
Pelizza L, Pupo S. “Towards a name change of schizophrenia: is it really necessary?” European Archives of Psychiatry and Clinical Neuroscience 2025; https://doi.org/10.1007/s00406-025-02105-w.
Pelizza L, et al. “Mental health antecedents in first episode psychosis: impact on prognosis across transitional age”. European Child and Adolescent Psychiatry 2025; https://doi.org/10.1007/s00787-025-02880-w.
Pelizza L, et al. “What does the PANSS Autism Severity Score (PAUSS) really measure in patients with first episode psychosis? Critical considerations”. Journal of Autism and Developmental Disorders 2026; https://doi.org/10.1007/s10803-025-07197-w.
Pelizza L, et al. “Comorbid major psychopathology in chronic pain: a neglected clinical condition? Preliminary, descriptive results from the P3 study”. Journal of Psychopathology 2025; 31: 182-190. https://doi.org/10.36148/2284-0249-1588.
Pellegrini P, Leuci E, …, Pelizza L. “The Italian 2023 mental health report: a comment”. Journal of Psychopathology 2025; 31: 191-195. https://doi.org/10.36148/2284-0249-1596.
Pelizza L, et al. “Early intervention in psychosis: perceptions, strengths, criticalities, and improvement proposals from the perspective of Italian mental healthcare professionals”. Community Mental Health Journal 2026; https://doi.org/10.1007/s10597-025-01575-5.
Pelizza L, et al. “Comorbid DSM-5 mental disorders and chronic pain: what kind of relationship? Findings from the P3 cross-sectional study”. Journal of Psychosomatic Research 2026; https://doi.org/10.1016/j.jpsychores.2026.112549.
Pelizza L, et al. “A music therapy group intervention in an Italian prison: the subjective impact of a pilot program”. The Arts in Psychotherapy 2026; 98: 102434. https://doi.org/10.1016/j.aip.2026.102434.
Baldini V, Iannucci F, …, Pelizza L, Menchetti M. “Sleep in early psychosis: preliminary results on actigraphic and self-reported markers of vulnerability”. Early Intervention in Psychiatry 2026; 20: e70160. https://doi.org/10.1111/eip.70160.
Pelizza L, et al. “Exposure to antipsychotics in youths at Clinical High Risk for psychosis: low vs high doses and their relevance for clinical outcomes”. Early Intervention in Psychiatry 2026; 20: e70167. https://doi.org/10.1111/eip.70167.
Pelizza L, et al. “Clinical factors influencing improvement in disorganization in clinical high risk for psychosis: preliminary findings from a 2-year follow-up”. Asia-Pacific Psychiatry 2026; 18:e70021. https://doi.org/10.1111/appy.70021.
Pelizza L, et al. “What psychiatric comorbidity in chronic pain? New insights for an old, underestimated issue”. Minerva Psychiatry 2026; 67. https://doi.org/10.23736/S2724-6612.26.02679-5.
Doroldi D, Origlia G, …, Pelizza L, Ciocca G. “Is problematic sexuality a marker for the onset of mental disorders? A cross-sectional study on psychotic-like experiences and sexual behaviour in a non-clinical sample”. Journal of Psychiatric Research 2026; 200: 63-70. https://doi.org/10.1016/j.jpsychires.2026.05.026.
Pelizza L, et al. “Sex-specific clinical profiles and long-term outcomes in adolescents and young people at clinical high risk for psychosis: findings from the PARMS program. European Child and Adolecent Psychiatry 2026; https://doi.org/10.1007/s00787-026-03082-8.
